These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22396243)

  • 1. Lead time TTO: leading to better health state valuations?
    Attema AE; Versteegh MM; Oppe M; Brouwer WB; Stolk EA
    Health Econ; 2013 Apr; 22(4):376-92. PubMed ID: 22396243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuations.
    Al Sayah F; Mladenovic A; Gaebel K; Xie F; Johnson JA
    Qual Life Res; 2016 Jan; 25(1):35-43. PubMed ID: 26216584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocols for time tradeoff valuations of health states worse than dead: a literature review.
    Tilling C; Devlin N; Tsuchiya A; Buckingham K
    Med Decis Making; 2010; 30(5):610-9. PubMed ID: 20068144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deriving time discounting correction factors for TTO tariffs.
    Attema AE; Brouwer WB
    Health Econ; 2014 Apr; 23(4):410-25. PubMed ID: 23564665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Would you rather be ill now, or later?
    Attema AE; Versteegh MM
    Health Econ; 2013 Dec; 22(12):1496-506. PubMed ID: 23229912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead time' approach.
    Devlin NJ; Tsuchiya A; Buckingham K; Tilling C
    Health Econ; 2011 Mar; 20(3):348-61. PubMed ID: 21308856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning effects in time trade-off based valuation of EQ-5D health states.
    Augestad LA; Rand-Hendriksen K; Kristiansen IS; Stavem K
    Value Health; 2012; 15(2):340-5. PubMed ID: 22433766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A shortcut to mean-based time tradeoff tariffs for the EQ-5D?
    Rand-Hendriksen K; Augestad LA; Dahl FA; Kristiansen IS; Stavem K
    Med Decis Making; 2012; 32(4):569-77. PubMed ID: 22247424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gap effect: discontinuities of preferences around dead.
    Stalmeier PF; Busschbach JJ; Lamers LM; Krabbe PF
    Health Econ; 2005 Jul; 14(7):679-85. PubMed ID: 15744750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A theoretical framework for TTO valuations of health.
    Buckingham K; Devlin N
    Health Econ; 2006 Oct; 15(10):1149-54. PubMed ID: 16786547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study.
    Essink-Bot ML; Stuifbergen MC; Meerding WJ; Looman CW; Bonsel GJ;
    BMC Health Serv Res; 2007 Apr; 7():62. PubMed ID: 17466068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test-retest reliability of health state valuation techniques: the time trade off and person trade off.
    Robinson S
    Health Econ; 2011 Nov; 20(11):1379-91. PubMed ID: 21053203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constantly proving the opposite? A test of CPTO using a broad time horizon and correcting for discounting.
    Attema AE; Brouwer WB
    Qual Life Res; 2012 Feb; 21(1):25-34. PubMed ID: 21505879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of alternative variants of the lead and lag time TTO.
    Devlin N; Buckingham K; Shah K; Tsuchiya A; Tilling C; Wilkinson G; van Hout B
    Health Econ; 2013 May; 22(5):517-32. PubMed ID: 22715069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of assumptions in using time tradeoff and standard gamble utilities in individuals with spinal cord injury.
    Lin MR; Yu WY; Wang SC
    Arch Phys Med Rehabil; 2012 Feb; 93(2):245-52. PubMed ID: 22289233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of subjective life expectancy on health state valuations using a 10 year TTO.
    van Nooten FE; Koolman X; Brouwer WB
    Health Econ; 2009 May; 18(5):549-58. PubMed ID: 18702082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring challenges to TTO utilities: valuing states worse than dead.
    Robinson A; Spencer A
    Health Econ; 2006 Apr; 15(4):393-402. PubMed ID: 16389652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of correcting values: influence and importance of correcting TTO scores for time preference.
    Attema AE; Brouwer WB
    Value Health; 2010 Dec; 13(8):879-84. PubMed ID: 20659269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lead time tradeoff: the case of health states better than dead.
    Pinto-Prades JL; Rodríguez-Míguez E
    Med Decis Making; 2015 Apr; 35(3):305-15. PubMed ID: 25009190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are people consistent when trading time for health?
    Oliver A; Wolff J
    Econ Hum Biol; 2014 Dec; 15():41-6. PubMed ID: 24953641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.